期刊文献+

细菌感染大鼠血中血小板型磷脂酶A_2 mRNA水平的变化及其cDNA克隆 被引量:2

Platelet phospholipase A_2 mRNA content changes and cDNA cloning in rat blood with bacteria infection
下载PDF
导出
摘要 目的 观察感染大鼠血中血小板型PLA2 mRNA水平的变化 ,研究其基因和氨基酸顺序结构的特征。为开发新的抗菌药物提供依据。方法 用半定量RT PCR方法检测感染大鼠血中PLA2 mRNA ,并对PLA2 cDNA进行克隆和序列分析。结果 大鼠感染细菌后 ,血中血小板型PLA2 mRNA水平迅速明显增加 ,其DNA和氨基酸结构与其他组织来源的PLA2 有高度的同源性。结论 细菌感染可引起大鼠血中PLA2 在基因水平上的迅速反应 ,这可使血小板型PLA2 的生成增加并控制感染。血中克隆出来的PLA2 cDNA与大鼠其他组织来源的PLA2 虽略有不同 。 Aim To explore the changes of rat platelet phospholipase A 2 (PLA 2) mRNA content in bacteria infected rat and study the cDNA and amino acid sequences of the PLA 2 structure to lay a good foundation for the development of new antibiotics. Methods The PLA 2 mRNA level in blood was determined by RT PCR. The DNA sequence was cloned and analyzed. Results After injection of bacteria in rats, the mRNA level of PLA 2 in blood increased markedly. The cDNA and amino acid sequence were highly homologous to o...
出处 《药学学报》 CAS CSCD 北大核心 2003年第5期321-324,共4页 Acta Pharmaceutica Sinica
基金 广西自然科学基金资助项目( 992 0 0 12 ) 国家人事部留学回国人员科技资助项目
关键词 血小板型磷脂酶A_2 细菌感染 信使RNA CDNA克隆 platelet phospholipase A 2 bacteria infection mRNA cDNA cloning
  • 相关文献

同被引文献17

  • 1梁宁生,李艳,杨帆,陆益,蒙子卿.重组人血小板型磷脂酶A_2杀菌作用的研究[J].中华医院感染学杂志,2004,14(10):1081-1083. 被引量:17
  • 2姚春艳,府伟灵.葡萄球菌医院感染的耐药性分析[J].中华医院感染学杂志,2004,14(1):104-106. 被引量:86
  • 3李艳,梁宁生.血小板型磷脂酶A_2抗菌活性的研究进展[J].国外医学(临床生物化学与检验学分册),2005,26(10):694-696. 被引量:12
  • 4Beers SA,Buckland AG,Koduri RS,et al. The antibacterial properties of secreted phospholipases Az: a major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of the bacterial cell wall. J Biol Chem,2002,277(3): 1 788-1 793.
  • 5Koprivnjak T, Peschel A, Gelb M, et al. Role of charge properties of bacterial envelope in bactericidal action of human group IIA phospholipase A2against Staphylococcus aureus. J Biol Chem,2002,277(49):47 636-47 644.
  • 6Koduri RS, Gronroos JO, Laine VJ, et al. Bactericidal properties of human and murine groups Ⅰ ,Ⅱ , Ⅴ, Ⅹ ,and Ⅹ Ⅱ secreted phospholipases A(2). J Biol Chem, 2002,277(8):5 849-5 857.
  • 7Laurence DR,Bennett PN,Brown MJ. Clinical Pharmacology. Eighth edition. Beiiing:Science Press,1999. 524-525.
  • 8Dua R, Cho W. Inhibition of human secretory class II phospholipase A2 by heparin. Eur J Biochem, 1994, 221( 1 ) :481-490.
  • 9Enomoto A, Murakami M, Kudo I. Internalization and degradation of type IIA phospholipase A (2) in mast cells. Biochem Biophys Res Commun ,2000,276(2):667-672.
  • 10Touqui L,Alaoui-El-Azher M. Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases. Curr Mol Med, 2001,1 (6) : 739-754.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部